Nurix – Talk Bio

Actionable Insights Powered by AI

Sanofi Increases Investment in Nurix-Partnership for STAT6 Program

6 days ago talkbio0Tagged Asthma, biotech collaboration, DEL-AI, Dermatitis, Atopic, Drug Discovery, Licensing Deal, Nurix, NX-3911, protein degrader, sanofi, STAT6

Sanofi; Nurix Therapeutics; STAT6; NX-3911; protein degrader; atopic dermatitis; asthma; drug discovery; licensing deal; DEL-AI platform; biotech collaboration

Sanofi adds new inflammatory target to growing Nurix tie-up

2 months ago talkbio0Tagged Autoimmune Diseases, cellular targeting, Collaboration, DEL-AI, Inflammation, Nurix, sanofi, STAT6 protein, human, Target, TRANSCRIPTION FACTOR

Nurix, sanofi, Target, STAT6 protein, human, cellular targeting, Collaboration, Inflammation, Autoimmune Diseases, TRANSCRIPTION FACTOR, DEL-AI